IL33 and interstitial lung disease: Our study clearly demonstrate that both IL-33 and TSLP levels were robustly increased in the patients with IPF compared with patients afflicted with other interstitial lung diseases, including HP, NSIP, and sarcoidosis, suggesting that the enhanced innate immune responses may be more related with the development of IPF than the other interstitial lung diseases.